Catalyst Wire Dossier Catalyst Wire Dossier

Cancidas (caspofungin)

caspofungin · Merck & Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cancidas (caspofungin), covering 2024-11-19 to 2024-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Caspofungin for Pneumocystis Pneumonia in PLWHIV.

See pricing